Preliminary report: ciprofibratefluvastatin combination therapy for dyslipidaemia

Journal of Drug Development and Clinical Practice

Volumn 8, Issue 3, 1996, Pages 171-175

  Ganotakis, E S ^a   Jagroop, I A ^b   Hamilton, G ^a   Winder, A F ^b   Mikhailidis, O P ^a,b,c  

^a Department of Chemical Pathology and Human Metabolism ^*  (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Fibrates; Myocardial infarction; Serum lipids; Statins

Indexed keywords

CIPROFIBRATE; FIBRIC ACID DERIVATIVE; FIBRINOGEN; FLUINDOSTATIN; LIPID; STATIN;

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY RISK; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0030478566     PISSN: 13579215     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The Scandinavian Simvastatin Survival Study Group. Lancet 1994;344:1383-1389.
2. Sacks FM, Pfeffer M, Moye L, et al. N Engl J Med 1996;335:1001-1009.
3. Shepherd J, Cobbe S, Ford I, et al. N Engl J Med 1995;333:1301-1307.
4. Betteridge DJ, Dodson PM, Durrington PN, et al. Postgrad Med J 1993;69:359-369.
5. Ganotakis ES, Mikhailidis DP. Today's Therap Trends 1996;13:231-249.
6. Leitersdorf E, Muratti E, Eliav O, et al. Am J Med 1994;96:401-07.
7. Shepherd J.Eur Heart J 1995;16:5-13.
8. Ericsson C-G, Hamsten A, Nilsson J, et al. Lancet 1996;347:849-853.
9. Austin MA, Edwards KL. Gurr Opin Lipidol 1996:7:167-171.
10. Manninen V, Tenkanen L, Koskinen P, et al. Circulation 1992;85:37-45.
11. Linden T, Bongjers G, Karlsson T, Wiklund O. Eur Heart J 1994; 15:747-752.
12. Griffin BA, Freeman DJ, Tait GW, et al. Atherosclerosis 1994;106:241-253.
13. Cheung MC, Austin MA, Moulin P, et al. Atherosclerosis 1993;102:107-119.
14. Hodis HN, Mack VVJ. Curr Opin Lipidol 1995;6:209-214.
15. Ernst E, Resch KL. Eur Heart J 1995;16(Suppl A):47-53.
16. KoenigW. Eur Heart J 1995;16(Suppl A):54-59.
17. Heinrich J, Balleisen L, Schulte H, et al. Arterioscler Thromb 1994;14:54-59. [Correction: Arterioscler Thromb 1994;14:1392],
18. Thompson SG, KiensatJ, Pyke SD, et al. N Engl J Med 1995;332:635-641.
19. Mikhailidis DP, Winder AE J Drug Dev Clin Pract 1995;7:3-5.
20. Famier M, Truong-Tan N, Regy C. J Drug Dev 1992;5:13-21.
21. British National Formulary 1996. Number 31, ppll2-115.
22. Bakker-Arkema RG, Davidson MH, Gcldstein RJ, et al. JAMA 1996;275:128-133.